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The study by Picano et al. (I) in this issue of the Journal
makes an interesting observation, that is, that regional left
ventricular function is transiently impaired during phar-
macologic coronary arteriolar vasodilation in the presence
of severe coronary artery stenosis. The authors suggest that
echocardiographic monitoring of left ventricular function
after intravenous dipyridamole is a good index of severity
of coronary artery stenoses. To interpret their findings in
perspective, a brief overview of the problem is appropriate.
Approaches to assessing coronary stenosis severity.
Quantifying the severity of coronary artery stenosis objec-
tively is becoming increasingly important in clinical car-
diology for many reasons . Quantitative measurements are
necessary I) for evaluating intervention therapy such as
cholesterolcontrol, stress management, pharmacologicagents,
percutaneou s transluminal coronary angioplasty and throm-
bolysis in acute myocardial infarction , 2) for comparison
with noninvasive diagnostic techniques, 3) for understand-
ing the critical role of fluid dynamics in atherogenesis, and
4) increasingly, for routine clinical decisions involving med-
ical versus mechanical treatment of coronary artery disease .
There are two fundamentally different approaches for de-
scribing stenosis severity (2). The anatomic-geometric ap-
proach utilizes all of the X-ray-determined geometric di-
mensions of a stenosis, including percent narrowing, absolute
diameter and length effects . These dimensions are integrated
throughout the length of the stenosis using fluid dynamic
equations to predict the pressure flow characteristics of the
stenosis (3- 5) or coronary flow reserve (6,7). Percent nar-
rowing or absolute diameter alone is commonly used, but
each is an incomplete approximation of the correct ana-
tomic-geometric method for describing severity (2,4,6-9).
In part because of the failure of these partial geometric
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descriptors to predict functional severity of stenoses , phys-
iologic measures have been developed. The best docu-
mented of these physiologic approaches depends on the
concept of coronary flow reserve, first proposed by Gould
(10) . It has evolved into an accepted clinical descriptor of
stenosis severity measured by a variety of technique s such
as perfusion imaging (7 ,11- 16), coronary sinus thermodi-
lution (17) or Doppler-tippedcoronary artery catheters (8,9 ,18)
in conjunction with pharmacologically induced increases in
coronary blood flow, most commonl y using intravenous
dipyridamole or intracoronary papaverine (7, 11- 18).
Physiologic assessment of coronary stenosis severity.
Recently , coronary flow reserve has been shown to be equiv-
alent to, interchangeable with and predicted by the ana-
tomic-geometric analysis of stenosis severity if all stenosis
dimension s are accounted for (6). Percent narrowing or ab-
solute dimensions alone correlate poorly with the degree of
impaired coronary flow reserve (6-9).
A variation of the physiologic approach to stenosis se-
verity utilizes indirect measurements such as chest pain,
electrocard iographic abnormalities or impaired global or re-
gionalleft ventricular function during exercise, pacing stress
or, in this study, pharmacologic coronary arteriolar vaso-
dilation. Typically, such end points are positive only in the
presence of fairly severe anatomic narrowing and may be
nonspecific for coronary atherosclerosis. For example, the
fall in global left ventricular ejection fraction with exercise
stress has a limited diagnostic specificity for coronary artery
disease with frequent false positive results (19,20) . As a
general rule, there is an inverse relation between sensitivity
and specificity for most indirect, noninvasive tests , thereby
limiting their clinical reliability (21,22) .
Role of coronary arteriolar vasodilation in evaluating
stenosis. Where does the study by Picano et al. (1) fit within
this perspective? The strength of their report is the inter-
esting observation that marked coronary arteriolar vasodi-
lation in the presence of single vessel disease of the left
anterior descending coronary artery may cause abnormal
function of the regional anterior left ventricular wall, usually
in association with chest pain and electrocardiographic
changes, all of which suggest transient myocardial ischemia .
However, the primary determinant of myocardial oxygen
demand and coronary blood flow, the pressure-rate product,
increased only modestly by 36 to 42% after dipyridamole
as compared with the usual increase of 200% or more during
exercise stress. Therefore, increased oxygen demand alone
could not explain the ischemic response after administration
of dipyridamole.
The interesting scientific question arising from this ob-
servation is why. What is the mechanism ? One explanation
proposed by the authors is epicardial -endocardial " steal"
associated with single vessel coronary artery disease. How-
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ever, this term is so unclear that a description of the hemo-
dynamics is necessary. The increased pressure drop across
a stenosis with elevated flow after coronary arteriolar vaso-
dilation causes a fall in distal perfusion pressure (2,4,5)
which may be sufficient to impair subendocardial perfusion.
Bache et al. (23) and Hoffman (24) have pointed out that
experimentally, under conditions of maximal coronary vaso-
dilation, lowered perfusion pressure is linearly related to a
fall in subendocardial perfusion. A fall in absolute suben-
docardial flow in single vessel disease after maximal arter-
iolar vasodilation has been documented (25-30) and termed
subendocardial "steal." This fall in subendocardial flow
may be sufficient to impair contraction in experimental an-
imals (26).
However, Smalling et al. (31) have shown that under
conditions of modest but not maximal coronary arteriolar
vasodilation, a marked decrease in perfusion pressure caused
by proximal stenosis did not impair regional left ventricular
function in experimental animals. Several differences in
experimental design could explain these divergent results.
An anesthetized, open chest preparation with a more potent
vasodilator was used in the study by Bache (23) and Forman
(26) and their coworkers. In Smalling's study, awake,
chronically instrumented animals were used, with only a
twofold increase in flow before imposition of a stenosis.
Accordingly, some vasodilator reserve may have remained,
thereby eliminating the linear relation between subendo-
cardial perfusion and perfusion pressure under conditions
of maximal arteriolar vasodilation, as seen in an anesthetized
dog with a more potent vasodilator stimulus. Other possible
explanations include collapsing stenoses or collaterals from
other normal arteries, so that classical "steal" by an ad-
jacent perfusion bed might occur instead of epicardial-
endocardial "steal." Thus, the strength of the study by
Picano et al. (l) is in the observation of impaired left ven-
tricular function after pharmacologic arteriolar vasodilation
in the presence of severe single vessel disease, a clinical
observation paralleling animal experiments (26).
Limitations of the study. However, from another per-
spective, the study by Picano et al. (l) is somewhat dis-
appointing. The authors conclude that 1) the dipyridamole
echocardiographic test is a good diagnostic method for as-
sessing functional stenosis severity, perhaps better than ar-
teriography; and 2) coronary arteriography is inadequate as
a categoric approach for assessing stenosis severity. To this
reviewer, it is not clear whether their methods or reported
data support these claims. The first conclusion regarding
the diagnostic utility of the dipyridamole echocardiographic
test may be moot for several reasons.
1) By their classification of patients into Groups IA and
IB, the authors, in effect, used a positive dipyridamole
echocardiographic test as the standard for significant coro-
nary artery disease, while at the same time purporting to
evaluate the accuracy of the test for diagnosing that disease.
For example, 6 of the 10 patients in Group IB had stenoses
of 80% diameter narrowing or greater, angina pectoris or
electrocardiographic changes on exercise testing, or both;
of these 6 patients with symptomatic significant coronary
artery disease, 3 also had angina after dipyridamole infu-
sion. Therefore, by most reasonable criteria of significant
coronary artery disease, the total number of patients with
functionally severe disease and evidence of stress ischemia
would be 15: these 6 patients from Group IB along with the
9 patients in Group IA. However, a positive dipyridamole
echocardiographic test with abnormal wall motion was seen
in only 9 of these 15 patients, for a diagnostic sensitivity
of only 60% for identifying a disease that is anatomically
severe and clinically significant. Even with such small num-
bers of patients, this sensitivity appears poor, particularly
for severe coronary lesions of no less than 80% diameter
narrowing.
2) Because only patients with isolated disease of the left
anterior descending coronary artery were studied, the di-
agnostic usefulness of the dipyridamole echocardiographic
test for disease of the right or left circumflex coronary artery,
for multivessel disease or for lesions with 50 to 80% di-
ameter narrowing has not been demonstrated. It seems likely
that disease of the right or left circumflex coronary artery
alone might not have as great an effect on left ventricular
function as disease of the left anterior descending artery.
Therefore, the value of the dipyridamole echocardiographic
test for assessing coronary artery disease in general would
be limited, perhaps with a sensitivity of less than 60%.
3) The underlying mechanism for a positive dipyridamole
echocardiographic test might reasonably be a fall in flow
("steal") in the distribution of the left anterior descending
coronary artery where stenosis was located. In this circum-
stance, a decrease in flow of the anterior great cardiac vein
would be expected. Table 1 in the article by Picano et al.
shows that after dipyridamole, flow in the anterior great
cardiac vein increased, but less than in normal subjects and
less than in patients in Group IB with purportedly milder
disease. The authors propose that subendocardial flow might
fall enough to impair function while epicardial flow might
increase enough to cause great vein flow to increase. How-
ever, many patients had evidence of transmural ischemia
with ST segment elevation and major regional left ventric-
ular dysfunction, all suggesting a decrease in transmural
flow. One might, therefore, question whether the technique
for measuring flow in the anterior cardiac vein provided
adequate information for identifying the mechanisms in-
volved. In any case, the dipyridamole echocardiographic
test appears to be of limited diagnostic value based on data
in this report.
Role of coronary arteriography. The second conclu-
sion of Picano et al. (I) regarding the inadequacy of standard
coronary arteriography is more appropriate. It is consistent
with previous work showing the inadequacy of percent di-
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ameter narrowing alone as a measure of stenosis severity,
beginning with that of Fiddian et al. (32) 20 years ago and,
most recently, the data obtained by direct measurements
using Doppler catheters (8,9) and by validated automated
arteriographic analysis of experimental and clinical arterio-
grams in our own laboratory (6,7). Picano et al. (1) have
added new information indicating that impaired ventricular
function may also be unrelated to percent narrowing. How-
ever, they have implied that quantitative coronary arteri-
ography as a general approach is inadequate. This reviewer
would emphasize that, properly done, quantitative coronary
arteriography that takes into account all dimensions of length,
absolute diameter and percent narrowing appears to cor-
rectly predict functional severity of stenoses as reflected by
coronary flow reserve (6,7). Perhaps it is worthwhile to
reiterate the limitations of percent diameter narrowing alone
as a measure of stenosis severity in view of its persistence
in otherwise sophisticated clinical investigation or practice.
Conclusions. In our highly competitive focused business
of science with its publish or perish creed, it is difficult to
remain sufficiently open and undirected to "let the data talk
to us." Instead, we often try to interpret the data to fit a
preconceived notion; in this study, that notion was diag-
nostic utility. Although nearly buried by the unsubstantiated
claim of diagnostic utility, the essential observation of the
study on altered left ventricular function after arteriolar
vasodilation in the presence of severe stenosis remains an
interesting contribution to the clinical literature.
This reviewer, as both laboratory scientist and clinician,
has a personal need for hard, reliable data before making
experimental or clinical conclusions. Having observed in-
direct measures of stenosis severity over the years, I con-
clude that severity of coronary artery stenoses can be de-
termined at the present time only by direct measurements
of coronary flow reserve or of all stenosis dimensions, in-
cluding absolute diameter, percent narrowing and integrated
length effects. Of current noninvasive approaches, no tech-
nique now provides an adequate measure of stenosis se-
verity, although quantitative perfusion imaging by positron
emission tomography (7) demonstrates considerable poten-
tial. In addition, such advanced imaging technology might
clarify the mechanism for the interesting observation made
by Picano and his colleagues (I) by providing information
on perfusion or myocardial steal. However, at present, quan-
titative coronary arteriography, taking into account all ste-
nosis dimensions, remains the only validated, routinely ap-
plicable, reference standard for assessing severity of coronary
artery stenosis and making definitive investigational or clin-
ical decisions.
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